array:24 [ "pii" => "S238702061630047X" "issn" => "23870206" "doi" => "10.1016/j.medcle.2016.04.025" "estado" => "S300" "fechaPublicacion" => "2015-12-21" "aid" => "3265" "copyright" => "Elsevier España, S.L.U.. All rights reserved" "copyrightAnyo" => "2015" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2015;145:551-2" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2 "HTML" => 2 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0025775315001360" "issn" => "00257753" "doi" => "10.1016/j.medcli.2015.02.018" "estado" => "S300" "fechaPublicacion" => "2015-12-21" "aid" => "3265" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2015;145:551-2" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 577 "formatos" => array:2 [ "HTML" => 9 "PDF" => 568 ] ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta al Editor</span>" "titulo" => "Síndrome de reconstitución inmunitaria en un caso de sarcoma de Kaposi asociado a sida con desenlace mortal" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "551" "paginaFinal" => "552" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Fatal outcome of immune reconstitution inflammatory síndrome in a patient with AIDS-associated Kaposi sarcoma" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1023 "Ancho" => 3167 "Tamanyo" => 456612 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A y B. Imágenes del empeoramiento del sarcoma de Kaposi al mes de iniciar el tratamiento antirretroviral de gran actividad. Aumento del número y tamaño de las lesiones de sarcoma de Kaposi asociado a sida. C. Imágenes durante el ingreso en la Unidad de Cuidados Intensivos del continuo empeoramiento del sarcoma de Kaposi. Aumento del volumen de las lesiones de sarcoma de Kaposi asociado a sida y aparición de púrpura perilesional debido a la trombocitopenia.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Gemma Melé-Ninot, Joaquim Sola-Ortigosa, Maribel Iglesias-Sancho, Jordi Delás-Amat" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Gemma" "apellidos" => "Melé-Ninot" ] 1 => array:2 [ "nombre" => "Joaquim" "apellidos" => "Sola-Ortigosa" ] 2 => array:2 [ "nombre" => "Maribel" "apellidos" => "Iglesias-Sancho" ] 3 => array:2 [ "nombre" => "Jordi" "apellidos" => "Delás-Amat" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S238702061630047X" "doi" => "10.1016/j.medcle.2016.04.025" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S238702061630047X?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775315001360?idApp=UINPBA00004N" "url" => "/00257753/0000014500000012/v1_201512060029/S0025775315001360/v1_201512060029/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2387020616300481" "issn" => "23870206" "doi" => "10.1016/j.medcle.2016.04.026" "estado" => "S300" "fechaPublicacion" => "2015-12-21" "aid" => "3267" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2015;145:552-3" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Gastroparesis: An under-recognized complication after atrial fibrillation catheter ablation procedure" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "552" "paginaFinal" => "553" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Gastroparesia: una complicación poco reconocida de la ablación percutánea de la fibrilación auricular" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Naiara Calvo, Manuel García de Yébenes-Castro, Hugo Arguedas, Ignacio García-Bolao" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Naiara" "apellidos" => "Calvo" ] 1 => array:2 [ "nombre" => "Manuel" "apellidos" => "García de Yébenes-Castro" ] 2 => array:2 [ "nombre" => "Hugo" "apellidos" => "Arguedas" ] 3 => array:2 [ "nombre" => "Ignacio" "apellidos" => "García-Bolao" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0025775315001402" "doi" => "10.1016/j.medcli.2015.03.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775315001402?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020616300481?idApp=UINPBA00004N" "url" => "/23870206/0000014500000012/v1_201605120032/S2387020616300481/v1_201605120032/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2387020616300468" "issn" => "23870206" "doi" => "10.1016/j.medcle.2016.04.024" "estado" => "S300" "fechaPublicacion" => "2015-12-21" "aid" => "3351" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Med Clin. 2015;145:545-50" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Diagnosis and treatment</span>" "titulo" => "Update of treatment in chronic heart failure" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "545" "paginaFinal" => "550" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Actualización en las estrategias terapéuticas de la insuficiencia cardiaca crónica" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Jesús Casado Cerrada, Vicente Gómez del Olmo, Luis Manzano" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Jesús" "apellidos" => "Casado Cerrada" ] 1 => array:2 [ "nombre" => "Vicente" "apellidos" => "Gómez del Olmo" ] 2 => array:2 [ "nombre" => "Luis" "apellidos" => "Manzano" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0025775315003590" "doi" => "10.1016/j.medcli.2015.06.009" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775315003590?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020616300468?idApp=UINPBA00004N" "url" => "/23870206/0000014500000012/v1_201605120032/S2387020616300468/v1_201605120032/en/main.assets" ] "en" => array:16 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Fatal outcome of immune reconstitution inflammatory syndrome in a patient with AIDS-associated Kaposi sarcoma" "tieneTextoCompleto" => true "saludo" => "Dear Editor," "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "551" "paginaFinal" => "552" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Gemma Melé-Ninot, Joaquim Sola-Ortigosa, Maribel Iglesias-Sancho, Jordi Delás-Amat" "autores" => array:4 [ 0 => array:4 [ "nombre" => "Gemma" "apellidos" => "Melé-Ninot" "email" => array:1 [ 0 => "gemmameleninot@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Joaquim" "apellidos" => "Sola-Ortigosa" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 2 => array:3 [ "nombre" => "Maribel" "apellidos" => "Iglesias-Sancho" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 3 => array:3 [ "nombre" => "Jordi" "apellidos" => "Delás-Amat" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Servicio de Dermatología, Hospital Universitari Sagrat Cor, Barcelona, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Servicio de Medicina Interna, Hospital Universitari Sagrat Cor, Barcelona, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Síndrome de reconstitución inmunitaria en un caso de sarcoma de Kaposi asociado a sida con desenlace mortal" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 614 "Ancho" => 1899 "Tamanyo" => 249537 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">(A and B) Images of worsening of Kaposi sarcoma a month after starting highly active antiretroviral therapy. Increasing number and size of injuries of AIDS-associated Kaposi sarcoma. (C) Images, during admission to the Intensive Care Unit, of the continuing Kaposi sarcoma worsening. Increased volume of AIDS-associated Kaposi sarcoma injuries and appearance of purpura due to thrombocytopenia.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">The incidence of AIDS-associated Kaposi sarcoma (AIDS-KS) has decreased dramatically in recent years as a result of the widespread use of highly active antiretroviral therapy (HAART). There is a potential worsening or appearance of AIDS-KS with the onset of HAART despite the paradoxical improvement in immune function. This process is called immune reconstitution inflammatory syndrome associated with Kaposi sarcoma (KS-IRIS), of which there are about 50 cases reported in medical literature.<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">1</span></a> We report a case of AIDS-KS with torpid evolution due to KS-IRIS.</p><p id="par0010" class="elsevierStylePara elsevierViewall">It is a 22-year-old male diagnosed with infection by the human immunodeficiency virus (HIV), classified as a category A3 according to the CDC system and with AIDS-KS lesions. One month after starting HAART with emtricitabine, tenofovir and efavirenz, the patient showed rapid improvement in immune function and a paradoxical worsening of AIDS-KS. Previous injuries increased in size and new skin (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>A and B), oropharyngeal and digestive injures appeared. Therefore, he was diagnosed with KS-IRIS. Because of a refractory thrombocytopenia, the patient could not be administered doxorubicin for the treatment of AIDS-KS. The patient showed a nosocomial pneumonia that required admission to ICU. During hospitalization AIDS-KS injuries gradually increased in size, now accompanied by purpura (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>C), and facial swelling was becoming more evident. Subsequently, there was a multi-organ failure that caused the patient's death.</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0015" class="elsevierStylePara elsevierViewall">AIDS-KS is distinctive of AIDS and may be the first manifestation in these patients in 15% cases.<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">2</span></a> In 1994 Chang et al. identified HHV8 as a causative agent, although recently it has been believed that HIV infection may have a role in the development of KS through the action of the transcription-transactivating protein.<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">3</span></a> The AIDS Clinical Trials Group Oncology Committee<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">4</span></a> published the criteria for the evaluation of AIDS-KS, considering, as high risk factors, any of the following: tumor-associated edema or ulceration, extensive oral disease, gastrointestinal KS or in other viscera, CD4<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>150/mm<span class="elsevierStyleSup">3</span>, history of opportunistic infection, thrush, symptoms B or Karnofsky index <70. The patient reported 4 high risk factors: tumor-associated edema or ulceration, extensive oral disease, visceral involvement and CD4<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>150/μl. Patients treated with HAART where KS appears have a less aggressive disease compared to those who did not undergo HAART,<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">5</span></a> as in this case. The vast majority of patients have skin lesions only, and, if visceral involvement, it is usually gastrointestinal and in lung. The first-line treatment is HAART (a protease inhibitor should be included) and it can be combined with different local therapies.<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">5</span></a> The use of chemotherapy has been indicated in diffuse mucocutaneous involvement, visceral involvement, large extension (>25 lesions) or rapid progression.<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">5</span></a> First-line chemotherapy is PEGylated liposomal doxorubicin 20<span class="elsevierStyleHsp" style=""></span>mg/m<span class="elsevierStyleSup">2</span> intravenously every 2 weeks or daunorubicin citrate liposome 40<span class="elsevierStyleHsp" style=""></span>mg/m<span class="elsevierStyleSup">2</span> intravenously every 2 weeks. Paclitaxel has been indicated only for patients with recurrence or refractory to first-line chemotherapy.<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">5</span></a> HAART causes partial or complete AIDS-KS injury resolution in 55–60%,<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">6</span></a> but there is a risk of KS-IRIS. KS-IRIS is an inflammatory process in which there is paradoxically a temporary relationship between the onset of HAART, the onset or progression of AIDS-KS and improved immune status evidenced by a decreased viral load and increased CD4 count.<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">7</span></a> KS patients with low basal CD4 count appear to have increased risk of KS-IRIS,<a class="elsevierStyleCrossRefs" href="#bib0090"><span class="elsevierStyleSup">8,9</span></a> rapid increased CD4 count during HAART onset,<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">10</span></a> high viral load of HIV,<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">9</span></a> edema associated,<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">10</span></a> KS present clinically prior to HAART, HHV8 detectable in plasma and hematocrit >30%.<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">7</span></a> Corticosteroids are not recommended because they would promote HHV8 and growth factor replication. Thus, KS would be worsened.<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">7</span></a> KS early identification and previous or combined use of chemotherapy with HAART appears to be the most effective procedure to prevent the consequences of KS-IRIS<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">7</span></a> and reduce mortality.<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">1</span></a> In conclusion, it is important to understand this entity, and not to be confused with a failure of HAART, and know it does not imply a change of antiretroviral therapy, except in cases with potential irreversible damage.<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">7</span></a></p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Conflict of interests</span><p id="par0020" class="elsevierStylePara elsevierViewall">The authors report no conflict of interest in drafting the manuscript.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Conflict of interests" ] 1 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Melé-Ninot G, Sola-Ortigosa J, Iglesias-Sancho M, Delás-Amat J. Síndrome de reconstitución inmunitaria en un caso de sarcoma de Kaposi asociado a sida con desenlace mortal. Med Clin (Barc). 2015;145:551–552.</p>" ] ] "multimedia" => array:1 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 614 "Ancho" => 1899 "Tamanyo" => 249537 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">(A and B) Images of worsening of Kaposi sarcoma a month after starting highly active antiretroviral therapy. Increasing number and size of injuries of AIDS-associated Kaposi sarcoma. (C) Images, during admission to the Intensive Care Unit, of the continuing Kaposi sarcoma worsening. Increased volume of AIDS-associated Kaposi sarcoma injuries and appearance of purpura due to thrombocytopenia.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:10 [ 0 => array:3 [ "identificador" => "bib0055" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "E. Letang" 1 => "J.J. Lewis" 2 => "M. Bower" 3 => "A. Mosam" 4 => "M. Borok" 5 => "T.B. Campbell" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/QAD.0b013e328360a5a1" "Revista" => array:6 [ "tituloSerie" => "AIDS" "fecha" => "2013" "volumen" => "27" "paginaInicial" => "1603" "paginaFinal" => "1613" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23462220" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0060" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Characteristics of Kaposi's sarcoma: a retrospective study in a reference hospital" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "J.A. Avilés Izquierdo" 1 => "C.R. García-Andrade" 2 => "L.P. Gómez-Cornejo" 3 => "P. Lazaro Ochaíta" 4 => "J. de Portugal Alvarez" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "An Med Interna" "fecha" => "2003" "volumen" => "20" "paginaInicial" => "170" "paginaFinal" => "174" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12768828" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0065" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Kaposi sarcoma: no longer an AIDS-defining illness? A retrospective study of Kaposi sarcoma cases with CD4 counts above 300/mm<span class="elsevierStyleSup">3</span> at presentation" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "M.L. Daly" 1 => "A. Fogo" 2 => "C. McDonald" 3 => "R. Morris-Jones" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/ced.12163" "Revista" => array:6 [ "tituloSerie" => "Clin Exp Dermatol" "fecha" => "2014" "volumen" => "39" "paginaInicial" => "7" "paginaFinal" => "12" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23691969" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0070" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "AIDS-related Kaposi's sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "S.E. Krown" 1 => "M.A. Testa" 2 => "J. Huang" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1200/jco.1997.15.9.3085" "Revista" => array:6 [ "tituloSerie" => "J Clin Oncol" "fecha" => "1997" "volumen" => "15" "paginaInicial" => "3085" "paginaFinal" => "3092" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9294471" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0075" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Kaposi's sarcoma in HIV-positive patients: the state of art in the HAART-era" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "L. La Ferla" 1 => "M.R. Pinzone" 2 => "G. Nunnari" 3 => "F. Martellotta" 4 => "A. Lleshi" 5 => "U. Tirelli" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Eur Rev Med Pharmacol Sci" "fecha" => "2013" "volumen" => "17" "paginaInicial" => "2354" "paginaFinal" => "2365" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24065230" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0080" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma during potent antiretroviral therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "E. Connick" 1 => "M.A. Kane" 2 => "I.E. White" 3 => "J. Ryder" 4 => "T.B. Campbell" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1086/426078" "Revista" => array:6 [ "tituloSerie" => "Clin Infect Dis" "fecha" => "2004" "volumen" => "39" "paginaInicial" => "1852" "paginaFinal" => "1855" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15578411" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0085" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A fatal case of Kaposi sarcoma due to immune reconstitution inflammatory syndrome" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "K.R. Stover" 1 => "S. Molitorisz" 2 => "E. Swiatlo" 3 => "C.A. Muzny" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/MAJ.0b013e31823eff35" "Revista" => array:6 [ "tituloSerie" => "Am J Med Sci" "fecha" => "2012" "volumen" => "343" "paginaInicial" => "421" "paginaFinal" => "425" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22227511" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0090" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk of Kaposi sarcoma during the first months on combination antiretroviral therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.M. Lacombe" 1 => "F. Boue" 2 => "S. Grabar" 3 => "N. Viget" 4 => "S. Gazaignes" 5 => "A.S. Lascaux-Cametz" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/QAD.0b013e32835cba6c" "Revista" => array:6 [ "tituloSerie" => "AIDS" "fecha" => "2013" "volumen" => "27" "paginaInicial" => "635" "paginaFinal" => "643" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23196937" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0095" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Human immunodeficiency virus-associated Kaposi sarcoma as an immune reconstitution inflammatory syndrome: a literature review and case report" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "L. Feller" 1 => "C. Anagnostopoulos" 2 => "N.H. Wood" 3 => "M. Bouckaert" 4 => "E.J. Raubenheimer" 5 => "J. Lemmer" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1902/jop.2008.070225" "Revista" => array:6 [ "tituloSerie" => "J Periodontol" "fecha" => "2008" "volumen" => "79" "paginaInicial" => "362" "paginaFinal" => "368" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18251652" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0100" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Bower" 1 => "M. Nelson" 2 => "A.M. Young" 3 => "C. Thirlwell" 4 => "T. Newsom-Davis" 5 => "S. Mandalia" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1200/JCO.2005.14.597" "Revista" => array:6 [ "tituloSerie" => "J Clin Oncol" "fecha" => "2005" "volumen" => "23" "paginaInicial" => "5224" "paginaFinal" => "5228" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16051964" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/23870206/0000014500000012/v1_201605120032/S238702061630047X/v1_201605120032/en/main.assets" "Apartado" => array:4 [ "identificador" => "43309" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/23870206/0000014500000012/v1_201605120032/S238702061630047X/v1_201605120032/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S238702061630047X?idApp=UINPBA00004N" ]
Journal Information
Vol. 145. Issue 12.
Pages 551-552 (December 2015)
Share
Download PDF
More article options
Vol. 145. Issue 12.
Pages 551-552 (December 2015)
Letter to the Editor
Fatal outcome of immune reconstitution inflammatory syndrome in a patient with AIDS-associated Kaposi sarcoma
Síndrome de reconstitución inmunitaria en un caso de sarcoma de Kaposi asociado a sida con desenlace mortal
Visits
3
This item has received
Article information
These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscribe
Purchase
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail